ABU DHABI/WAM UAE President His Highness Sheikh Mohamed bin Zayed Al Nahyan has issued a …
Read More »EDD approves world’s first oral therapy for immune thrombocytopenia
ABU DHABI / WAM The Emirates Drug Establishment (EDE) has granted official approval for Rilzabrutinib, the first oral Bruton’s tyrosine kinase (BTK) inhibitor to be authorised in the country for the treatment of Immune Thrombocytopenia (ITP), a rare autoimmune disorder that affects approximately 2 to 5 individuals per 100,000 people worldwide. With this landmark approval, the UAE becomes the first …
Read More »
The Gulf Time Newspaper One of the finest business newspapers in the UAE brought to you by our professional writers and editors.



